Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for The Beauty Health Company (SKIN : NSDQ)

• Company Description    The Beauty Health Company is a beauty health company. Its flagship brand HydraFacial is a non-invasive and approachable beauty health platform and ecosystem with a powerful community of estheticians, consumers and partners, bridging medical and consumer retail to democratize and personalize skin care solutions for the masses. The Beauty Health Company, formerly known as Vesper Healthcare Acquisition Corp., is based in CHICAGO, Utah. Number of Employees: 613

• Price / Volume Information    Yesterday's Closing Price: $1.13 Daily Weekly Monthly 20 Day Moving Average: 857,487 shares Shares Outstanding: 127.77 (millions) Market Capitalization: $144.38 (millions) Beta: 1.20 52 Week High: $2.69 52 Week Low: $0.78 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 20.21% 27.66% 12 Week -22.60% -17.57% Year To Date -18.70% -14.47%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2165 SPRING STREET - LONG BEACH,CA 90806 USA ph: 800-603-4996 fax: - ir@beautyhealth.com http://www.beautyhealth.com

• General Corporate Information    Officers Pedro Malha - Chief Executive Officer and Director Brenton L. Saunders - Chairman Michael Monahan - Chief Financial Officer Philippe Schaison - Director Stephen J. Fanning - Director Peer Information The Beauty Health Company (CHCR) The Beauty Health Company (ESRX) The Beauty Health Company (MYDP) The Beauty Health Company (COR) The Beauty Health Company (GBCS) The Beauty Health Company (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 88331L108 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/14/26 Share - Related Items Shares Outstanding: 127.77 Most Recent Split Date: (:1) Beta: 1.20 Market Capitalization: $144.38 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.08 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.17 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/14/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.36 Price/Cash Flow: 7.40 Price / Sales: 0.48 EPS Growth vs. Year Ago Period: 25.00% vs. Previous Quarter: 33.33% Sales Growth vs. Year Ago Period: -1.32% vs. Previous Quarter: 16.55% ROE 12/31/25 - -15.40 09/30/25 - -19.70 06/30/25 - -32.82 ROA 12/31/25 - -1.74 09/30/25 - -1.97 06/30/25 - -2.96 Current Ratio 12/31/25 - 1.66 09/30/25 - 4.98 06/30/25 - 5.15 Quick Ratio 12/31/25 - 1.40 09/30/25 - 4.07 06/30/25 - 4.15 Operating Margin 12/31/25 - -3.16 09/30/25 - -3.87 06/30/25 - -6.13 Net Margin 12/31/25 - -3.16 09/30/25 - -3.87 06/30/25 - -6.13 Pre-Tax Margin 12/31/25 - -1.97 09/30/25 - -4.25 06/30/25 - -5.98 Book Value 12/31/25 - 0.48 09/30/25 - 0.52 06/30/25 - 0.58 Inventory Turnover 12/31/25 - 1.82 09/30/25 - 1.70 06/30/25 - 1.79 Debt-to-Equity 12/31/25 - 3.94 09/30/25 - 5.53 06/30/25 - 4.91 Debt-to-Capital 12/31/25 - 79.75 09/30/25 - 84.70 06/30/25 - 83.07

Powered by Zacks Investment Research ©